Form 4: Quaker Chemical Director Sanjay Hinduja Reports Routine Stock Transactions and New Equity Grant

Quaker Chemical Corporation Director Sanjay Hinduja reported the conversion of restricted stock units and dividend equivalent rights into common stock, alongside the grant of new time-based restricted stock units as part of his 2025 compensation.

Summary

• Sanjay Hinduja, a Director of Quaker Chemical Corp (KWR), reported changes in his beneficial ownership of company securities.
• On May 31, 2025, 716 Restricted Stock Units (RSUs) were converted into common stock.
• Concurrently, 9 Dividend Equivalent Rights (DERs) were settled into common stock on the same date.
• Following these transactions, Mr. Hinduja's direct beneficial ownership of Common Stock increased to 3,977 shares.
• On June 1, 2025, Mr. Hinduja was granted an additional 1,198 time-based Restricted Stock Units.
• These newly granted RSUs are part of his 2025 compensation under the Company's Long-Term Performance Incentive Plan for non-executive directors.

Sentiment

Score: 7

Explanation: The document reports routine insider transactions related to compensation, including the vesting of existing awards and the grant of new equity. This is a positive sign of continued alignment between management and shareholder interests, with no negative implications or red flags.

Positives

• Director Sanjay Hinduja received a new grant of 1,198 Restricted Stock Units, indicating continued alignment of interests with shareholders through equity compensation.
• The vesting and conversion of previous Restricted Stock Units and Dividend Equivalent Rights demonstrate the execution of the company's long-term incentive plan.

Future Outlook

The newly granted 1,198 Restricted Stock Units to Director Sanjay Hinduja are scheduled to vest 100% on May 31, 2026, indicating future equity compensation realization.

Industry Context

This Form 4 filing reflects a standard practice of public companies to compensate non-executive directors with equity, aligning their interests with long-term shareholder value. Such grants are common across various industries as part of corporate governance and incentive structures.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of non-executive director compensation is a widely adopted practice among publicly traded companies, including peers in the specialty chemicals sector.
• This aligns with best practices for corporate governance by linking director incentives to company performance and shareholder returns. Specific comparable companies or projects are not detailed in this filing, but the compensation structure is consistent with general industry norms for director remuneration.

Corporate Governance

Stakeholder Impact

• **Shareholders**: Minor dilution from the conversion of RSUs into common stock, but this is a standard component of executive and director compensation plans designed to align interests.
• **Director (Sanjay Hinduja)**: Receives additional equity in the company, increasing his direct beneficial ownership and aligning his financial interests with the company's performance.

Next Steps

• The 1,198 Restricted Stock Units granted on June 1, 2025, are expected to vest on May 31, 2026.
• Dividend equivalent rights will continue to accrue on the newly granted Restricted Stock Units when and as dividends are paid on KWR's common stock.

Key Dates

Keywords

Quaker Chemical Corp, KWR, SEC Form 4, Insider Trading, Beneficial Ownership, Restricted Stock Units, Dividend Equivalent Rights, Equity Compensation, Director Compensation